Healthcare resource utilization comparing single-use ureteroscopes with real-time intrarenal pressure monitoring to other single-use ureteroscopes

Auteurs-es

  • Naeem Bhojani Division of Urology, Université de Montréal, Montréal, PQ, Canada
  • Connor M. Forbes Department of Urologic Sciences, The University of British Columbia, Vancouver, Canada
  • Ben H. Chew Department of Urologic Sciences, The University of British Columbia, Vancouver, Canada
  • Kathryn Morris Boston Scientific, Marlborough, MA, USA
  • Theodore Tsacogianis Boston Scientific, Marlborough, MA, USA
  • Jenifer White Boston Scientific, Marlborough, MA, USA
  • Sirikan Rojanasarot Boston Scientific, Marlborough, MA, USA
  • Abimbola Williams
  • Natalie Edwards Health Services Consulting Corporation, Boxborough, MA, USA
  • Manoj Monga Department of Urology, University of California San Diego School of Medicine, La Jolla, CA, USA

DOI :

https://doi.org/10.5489/cuaj.9608

Mots-clés :

ureteroscopy; lithotripsy; LithoVue Elite; single-use ureteroscope; intrarenal pressure; pressure monitoring capability; emergency department visit; inpatient admission

Résumé

Introduction: This study compared post-procedure healthcare resource utilization with LithoVue™ Elite (LVE) single-use digital flexible ureteroscope with pressure monitoring vs. other (non-pressure sensing) single-use ureteroscopes.

Methods: This retrospective, real-world study used the Premier PINC AI™ Healthcare Database. Adults aged 18+ undergoing ureteroscopy (URS) with lithotripsy between January 1,2024 and March 1, 2025, with ≥30-day post-URS followup were included. The primary outcomes were 10- and 30-day hospital resource utilization (HRU), a composite measure of emergency department (ED) visits or inpatient admission. Propensity score matching (1:3) balanced baseline characteristics. Multivariable logistic regression in the matched cohort adjusted for residual confounding.

Results: A total of 305 patients underwent LVE with pressure monitoring capability (mean [standard deviation (SD)] age 58.6 [16.1], 51.1% female) and 15 048 underwent other single-use ureteroscopes (mean [SD] age 58.7 [15.8], 51.7% female). After matching, 292 LVE patients were compared with 876 controls. Patients undergoing LVE with pressure monitoring capability experienced improved HRU outcomes at 10-day (4.5% vs. 8.7%; ARR 4.2 pp, p=0.016) and 30-day (7.2% vs. 12.0%; ARR 4.8 pp, p=0.019) vs. other single-use ureteroscopes. In adjusted analyses, LVE with pressure monitoring capability was associated with lower odds of HRU at 10-day (odds ratio [OR] 0.355, 95% confidence interval [CI] 0.175-0.718, p=0.004) and 30-day (OR 0.473, 95% CI 0.281-0.797, p=0.005). The odds of 10-day ED visits (OR 0.385, 95% CI 0.149-0.997, p=0.049) and 30-day inpatient admissions (OR 0.436, 95% CI 0.196-0.967, p=0.041) were significantly lower with LVE with pressure monitoring capability.

Conclusions: Use of LVE with pressure monitoring capability was associated with clinically meaningful reductions in early post-URS HRU vs. other single-use ureteroscopes.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Publié-e

2026-03-30

Comment citer

Bhojani, N., Forbes, C. M., Chew, B. H., Morris, K., Tsacogianis, T., White, J., … Monga, M. (2026). Healthcare resource utilization comparing single-use ureteroscopes with real-time intrarenal pressure monitoring to other single-use ureteroscopes. Canadian Urological Association Journal, 20(8). https://doi.org/10.5489/cuaj.9608

Numéro

Rubrique

Original Research